Katharina Kriegsmann

5PUBLICATIONS
2CO-AUTHORS
Humoural immunology and immunochemistryHaematologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 22, 2020
Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma.

Xiang Zhou, Patrick Wuchter, Gerlinde Egerer

|Jul 25, 2019
Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B-cell lymphoma.

Xiang Zhou, Patrick Wuchter, Gerlinde Egerer

|Sep 07, 2018
NKT cells - New players in CAR cell immunotherapy?

Katharina Kriegsmann, Mark Kriegsmann, Michael von Bergwelt-Baildon

|Jul 27, 2018
Selective contrast-enhanced computed tomography is appropriate in diffuse large B-cell lymphoma therapy response assessment.

Katharina Kriegsmann, Maurizio Wack, Mark Kriegsmann

|May 26, 2018
CD7 is expressed on a subset of normal CD34-positive myeloid precursors.

Katharina Kriegsmann, Harald Löffler, Volker Eckstein

Pageof 1